Read More Pharma Industry News Lilly announces significant results in SURMOUNT-OSA trials of tirzepatide in OSA Eli Lilly and Company (NYSE: LLY) has released positive topline results from the phase 3 SURMOUNT-OSA clinical trials,… byPallavi MadhirajuApril 21, 2024